India: Food and Drugs Law

The Delhi High Court has ruled on a significant patent law question regarding whether making a fungicide stable at high temperatures constitutes an enhancement in efficacy under Section 3(d) of the Patents Act, 1970.

The law has long recognised an individual’s autonomy over personal decisions during life, but increasingly courts are being called upon to determine whether such autonomy extends beyond death.

The change is effected through two instruments: the Food Safety and Standards (Licensing and Registration of Food Businesses) Amendment Regulations, 2026, notified via gazette on 10th March, 2026[1] (the “Amendment Regulations”), and a subsequent implementation order dated 13th March, 2026[2] (the “Order”) issued by FSSAI directing all licensing authorities to apply the revised thresholds with effect from 1st April, 2026.

Explore comprehensive analyses of recent Indian tax rulings, FDI policy updates, and international trade agreements. From transfer pricing safe harbour rules to the India-New Zealand FTA, discover how regulatory changes impact cross-border transactions, foreign investment, and corporate tax compliance.

The Food Safety and Standards Authority of India has proposed amendments to packaging regulations that would mandate pan masala manufacturers to abandon plastic-based packaging in favor of paper, cellulose, tin, or glass materials. This regulatory intervention harmonizes food safety standards with environmental protection mandates by incorporating provisions from the Plastic Waste Management Rules, 2016, creating a comprehensive framework that addresses both public health and sustainability concerns. The dr

The present public interest litigation (PIL) is in the Supreme Court of India due to the promotion of stem cell “treatment” for Autism Spectrum Disorder (ASD).

India's life sciences and healthcare regulatory landscape continued to evolve in February 2026, with developments spanning drug pricing, clinical trial governance, medical device regulation and digital health policy.

This current edition of our Life Sciences and Healthcare Newsletter highlights key developments in the regulatory, policy and industry space that have taken place during January 2026.

India and the USA announce framework for Interim Agreement (07 Feb) Earlier this month, India and the USA announced the framework for Interim Agreement regarding reciprocal and mutually beneficial trade.